July 6, 2026 · Form 4 insider transaction
SAYER KEVIN R sold 26,756 shares of DexCom, Inc. at $72.00 per share, a transaction worth $1.93M. The trade was recorded as open-market sale and disclosed on an SEC Form 4, filed 1 day after the transaction.
On February 18, 2026, Mr. Sayer adopted a 10b5-1 Plan. This 10b5-1 Plan allows the orderly disposition of shares owned by Mr. Sayer. The shares set forth above were sold pursuant to the 10b5- 1 Plan.; Included in this number are 106,972 unvested restricted stock units, 32,749 of which were granted on March 8, 2026 and shall vest through March 8, 2027, 56,993 of which were granted on March 8, 2025 and shall vest through March 8, 2028, and 17,230 of which were granted on March 8, 2024 and shall vest through March 8, 2027.